Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia Calder

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Cells|June 10, 2022
Therapeutic Validation of GEF-H1 Using a De Novo Designed Inhibitor in Models of Retinal DiseaseClare Mills, Sandra A Hemkemeyer, Zerin Alimajstorovic, et al.
The Ocular Surface|May 18, 2018
Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trialJosé Pinto-Fraga, Amalia Enríquez-de-Salamanca, Margarita Calonge, et al.
Allergy|September 30, 2025
Drug-Induced Periocular and Ocular Surface Disorders: An EAACI Position PaperAndrea Leonardi, Banu Bozkurt, Diana Silva, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Cells|June 10, 2022
Therapeutic Validation of GEF-H1 Using a De Novo Designed Inhibitor in Models of Retinal DiseaseClare Mills, Sandra A Hemkemeyer, Zerin Alimajstorovic, et al.
The Ocular Surface|May 18, 2018
Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trialJosé Pinto-Fraga, Amalia Enríquez-de-Salamanca, Margarita Calonge, et al.
Allergy|September 30, 2025
Drug-Induced Periocular and Ocular Surface Disorders: An EAACI Position PaperAndrea Leonardi, Banu Bozkurt, Diana Silva, et al.
Pageof 3